Imaging Approaches in Prostate Cancer

Daniel P. Petrylak, MD, director, Prostate and GU Medical Oncology, Yale Cancer Center, describes imaging approaches in prostate cancer.

Clinical Pearls I

Daniel P. Petrylak, MD, director, Prostate and GU Medical Oncology, Yale Cancer Center, describes imaging approaches in prostate cancer.

  • Sodium fluoride PET represents a sensitive way of detecting bone metastases
  • Sodium fluoride PET is reasonable to use before treatment with enzalutamide, sipuleucel-T, or abiraterone, in patients with rising PSA and negative conventional imaging

Clinical Pearls II

  • The Artemis device is being looked at in clinical studies to help detect prostate cancer in localized biopsies
  • Sodium acetate PET and amino acid imaging are still under investigation
  • Petrylak is interested in research into imaging for targeted therapies to check for activity and eligibility